This suggests that individuals with a more central fat distribution might experience a downregulation of the adiponectin gene, which could contribute to metabolic dysregulation and increased risk of conditions like insulin resistance, type 2 diabetes, and cardiovascular diseases. This evidence concerns the gene ADIPOQ and Insulin resistance.